🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
LEN
$LENZ
🔒 US EquitiesLENZ Therapeutics Inc
AVG HISTORICAL GAP
-2.07%
MAX GAP RECORD
-23.12%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $LENZ
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$LENZ
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 28, 2026 Earnings Release 2026-10-28 (AFTER CLOSE (16:00)) |
-6.54%
|
| Aug 11, 2026 Earnings Release 2026-08-11 (AFTER CLOSE) |
+13.82%
|
| May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE) |
-23.12%
|
| Mar 24, 2026 Earnings Release 2026-03-24 (BEFORE OPEN) |
-4.82%
|
| Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN) |
-9.66%
|
| Jul 30, 2025 Earnings Release 2025-07-30 (BEFORE OPEN) |
-0.25%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
+0.00%
|
| Mar 19, 2025 Earnings Release 2025-03-19 (AFTER CLOSE) |
+8.03%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
7.0%
Bullish Gaps (4)
Bearish Gaps (4)
Neutral / Flat (2)
📖 Intelligence Summary
LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia. The company was founded by James W. McCollum in July 2013 and is headquartered in Solana Beach, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗